Nucleic acid synthesis methods

• US 9,957,502 B2
• Filed: 11/22/2002
• Issued: 05/01/2018
• Est. Priority Date: 11/22/2001
• Status: Active Grant

• Current Assignee: Morphosys Ag
• Original Assignee: Sloning BioTechnology GmbH
• Inventors: Schatz, Octavian, O'Connell, Timothy
• Primary Examiner(s): Sisson, Bradley L
• Application Number:
  US10/496,263
• Publication Number:
  US 20080044862A1
• Time in Patent Office: 5,639 Days
• Field of Search: None
• CPC Class Codes: C12N 15/10 Processes for the isolation, preparation or purification of DNA or RNA chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34
• CPC Class Codes: C12N 15/1093 General methods of preparing gene libraries, not provided for in other subgroups
• CPC Class Codes: C12N 15/66 General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
• CPC Class Codes: C12P 19/34 Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Abstract

The present invention relates to a single-stranded nucleic acid molecule for use in a method for the production of a nucleic acid, whereby the nucleic acid molecule comprises a part A and a part B, whereby part A comprises a sequence, which corresponds at least to a partial sequence of the recognition site of a type IIS restriction enzyme, and part B comprises an arbitrary but defined sequence of nucleotides. By using such nucleic acid molecules it is possible to assemble different fragments in a sequence-independent manner and thus conduct the synthesis of a nucleic acid with recourse to standardized elements.

Claims

1. A method comprising the steps:

a) providing a sequence of a defined nucleic acid molecule to be synthesized,

b) providing an oligonucleotide produced by the following steps;

ba) providing a partially double-stranded first oligonucleotide with a 5′

-overhang comprising a recognition site for a first type IIS restriction enzyme which cuts outside of its recognition site, wherein the first oligonucleotide comprises a modification which allows coupling to a solid matrix, wherein the 5′

-overhang has a length of 3 nucleotides,

bb) providing a partially double-stranded second oligonucleotide with a 5′

-overhang comprises a recognition site for a second type IIS restriction enzyme which cuts outside of its recognition site, the recognition site for the first and second type IIS restriction enzymes being different, wherein the 5′

-overhang has a length of 3 nucleotides,

bc) ligating the first and second oligonucleotides from steps ba) and bb) in the orientation defined by the blocking of the ends not to be ligated,

bd) removing unconsumed reactants as well as enzymes,

be) cleaving the ligation product from step bc) with the second type IIS restriction enzyme which cuts outside of its recognition site, wherein the cleavage occurs in the nucleic acid sequence of the second oligonucleotide from step bb), creating a first elongated product, wherein the first elongated product comprises the first oligonucleotide from step ba) which has been elongated, bf) separating the reaction mixture from the first elongated product,

c) providing a further oligonucleotide produced by the following steps;

ca) providing a partially double-stranded third oligonucleotide with a 5′

-overhang, comprising a recognition site for a third type IIS restriction enzyme which cuts outside of its recognition site, wherein the third oligonucleotide comprises a modification which allows coupling to a solid matrix, wherein the 5′

-overhang has a length of 3 nucleotides,

cb) providing a partially double-stranded fourth oligonucleotide with a 5′

-overhang comprising a recognition site for a fourth type IIS restriction enzyme which cuts outside of its recognition site, the recognition sites of the third and fourth type IIS restriction enzymes being different, wherein the 5′

-overhang has a length of 3 nucleotides,

cc) ligating the third and fourth oligonucleotides from steps ca) and cb) in the orientation defined by the blocking of the ends not to be ligated,

cd) removing unconsumed reactants as well as enzymes,

ce) cleaving the ligation product from step cc) with the fourth type IIS restriction enzyme, which cuts outside of its recognition site, whereby the cleavage occurs in the fourth oligonucleotide in step cb), creating a second elongated product, wherein the second elongated product comprises the third oligonucleotide from step ca) which has been elongated,

cf) separating the reaction mixture from the second elongated product,

d) ligating the first and second elongated products from steps b) and c) in the orientation defined by the blocking of the ends not to be ligated,

e) removing unconsumed reactants as well as enzymes,

f) cleavage of the ligation product from step d) with a type IIS restriction enzyme which cuts outside of its recognition site, whereby the cleavage occurs in the first or second elongated product from steps b) or c), thus creating a third elongated product,

g) separating the third elongated product from the reaction mixture, characterized in that the second oligonucleotide from step bb) has the recognition site for a type IIS restriction enzyme which generates an overhang three nucleotides in length as long as steps bb) to be) are repeated and the second oligonucleotide from step bb) has the recognition site for a type IIS restriction enzyme which generates an overhang other than an overhang three nucleotides in length, in the last cycle of the steps bb) to be) and/or the fourth oligonucleotide from step cb) has the recognition site for a type IIS restriction enzyme which generates an overhang three nucleotides in length, as long as steps cb) to ce) are repeated and the fourth oligonucleotide from step cb) has the recognition site of a type IIS restriction enzyme, which produces an overhang other than an overhang three nucleotides in length, in the last cycle of the steps cb) to ce) and

h) isolating the nucleic acid molecule or part thereof having the sequence provided in step a).

2. The method according to claim 1, characterized in that, following step bf), steps bb) to bf) are repeated at least once and/or, following step cf), steps cb) to ce) are repeated at least once, whereby, following the final ligation in step cc) and the removing of unconsumed reactants as well as enzymes, the final ligation product is cut with a type IIS restriction enzyme, whereby the cleavage occurs in the third oligonucleotide from step ca).

3. A method comprising the steps:

a) providing a sequence of a defined nucleic acid molecule to be synthesized,

b) providing an oligonucleotide produced by the following steps;

ba) providing a partially double-stranded first oligonucleotide comprising a 5′

overhang and a recognition site for a first type IIS restriction enzyme which cuts outside of its recognition site, wherein the 5′

overhang has a length of 3 nucleotides,

bb) providing a partially double-stranded second oligonucleotide comprising a 5′

overhang and a recognition site for a second type IIS restriction enzyme which cuts outside of its recognition site, the recognition sites of the first and second type IIS restriction enzymes being different, wherein the second oligonucleotide comprises a modification allowing coupling to a solid matrix, wherein the 5′

overhang has a length of 3 nucleotides,

bc) ligating the first and second oligonucleotides from steps ba) and bb) in the orientation defined by the blocking of the ends not to be ligated,

bd) cleaving the ligation product from step be) with the second type IIS restriction enzyme which cuts outside of its recognition site, wherein the cleavage occurs in the nucleic acid sequence of the second oligonucleotide from step bb), creating a first elongated product, wherein the first elongated product comprises the first oligonucleotide from step ba) which has been elongated,

bf) separating from the reaction mixture the first elongated product,

c) providing a further oligonucleotide produced by the following steps;

ca) providing a third oligonucleotide comprising a 5′

overhang and a recognition site for a third type IIS restriction enzyme, wherein the 5′

overhang has a length of 3 nucleotides,

cb) providing a partially double-stranded fourth oligonucleotide comprising a 5′

overhang and a recognition site for a fourth type IIS restriction enzyme which cuts outside of its recognition site, the recognition sites of the third and fourth type IIS restriction enzymes being different, wherein the fourth oligonucleotide comprises a modification which allows coupling to a solid matrix, wherein the 5′

overhang has a length of 3 nucleotides,

cc) ligating the third and fourth oligonucleotides from steps ca) and cb) in the orientation defined by the blocking of the ends not to be ligated,

ce) cleaving the ligation product from step cc) with a fourth type IIS restriction enzyme which cuts outside of its recognition site, whereby the cleavage occurs in the fourth oligonucleotide from step cb), creating a second elongated product, wherein the second elongated product comprises the third oligonucleotide from step ca) which has been elongated,

cf) separating from the reaction mixture the second elongated product from step ce),

d) ligating the first and second elongated products from steps b) and c) in the orientation defined by the blocking of the ends not to be ligated,

e) removing and/or inactivating unconsumed reactants as well as enzymes,

f) cleaving the ligation product from step d) with a type IIS restriction enzyme which cuts outside of its recognition site, whereby the cleavage occurs in the first or second elongated product from steps b) or c), creating a third elongated product,

g) separating the third elongated product from the reaction mixture, and

h) isolating the nucleic acid molecule or part thereof having the sequence provided in step a).

4. The method according to claim 3, characterized in that, following step bc), as step bd), unconsumed reactants as well as enzymes are removed and/or, following step bf), steps bb) to bf) are repeated at least once and/or, following step cf), steps cb) to cf) are repeated at least once, whereby, following the final ligation in step cc) and the removing and/or inactivating of unconsumed reactants as well as enzymes, the ligation product is cut using a third type IIS restriction enzyme, whereby the cleavage occurs in the third oligonucleotide from step ca).

5. The method according to claim 3, further comprising the step of transferring cleavage products that do not contain a modification to a new reaction.

6. The method according to claim 3, whereby step cd) follows step cc), and comprises cd) removing and/or inactivating unconsumed reactants as well as enzymes.

7. A method comprising the steps:

a) providing a sequence of a defined nucleic acid molecule to be synthesized,

b) providing an oligonucleotide produced by the following steps;

ba) providing a first oligonucleotide comprising a 5′

overhang and a recognition site for a first type IIS restriction enzyme which cuts outside of its recognition site, wherein the first oligonucleotide comprises a modification which allows coupling to a solid matrix, and coupling the first oligonucleotide to the solid matrix, wherein the 5′

overhang has a length of 3 nucleotides,

bb) providing a partially double-stranded second oligonucleotide comprising a 5′

overhang and a recognition site for a second type IIS restriction enzyme which cuts outside of its recognition site, the recognition site for the first and second type II restriction enzymes being different, wherein the 5′

overhang has a length of 3 nucleotides,

bc) ligating the first and second oligonucleotides from steps ba) and bb) in the orientation defined by the blocking of the ends not to be ligated,

bd) removing unconsumed reactants as well as enzymes,

be) cleaving the ligation product from step be) with the second type IIS restriction enzyme which cuts outside of its recognition site, wherein the cleavage occurs in the nucleic acid sequence of the second oligonucleotide from step bb), creating a first elongated product, wherein the first elongated product comprises the first oligonucleotide from step ba) which has been elongated,

bf) separating the reaction mixture from the first elongated product,

c) providing a further oligonucleotide produced by the steps;

ca) providing a third oligonucleotide comprising a 5′

overhang and a recognition site for a third type IIS restriction enzyme which cuts outside of its recognition site, wherein the third oligonucleotide comprises a modification which allows coupling to a solid matrix, coupling of the third oligonucleotide to the solid matrix, wherein the 5′

overhang has a length of 3 nucleotides,

cb) providing a partially double-stranded fourth oligonucleotide comprising a 5′

overhang and a recognition site for a fourth type IIS restriction enzyme which cuts outside of its recognition site, the recognition site of the third and fourth type IIS restriction enzymes being different, wherein the 5′

overhang has a length of 3 nucleotides,

cc) ligation of the third and fourth oligonucleotides from steps ca) and cb) in the orientation defined by the blocking of the ends not to be ligated,

cd) removing unconsumed reactants as well as enzymes,

ce) cleavage of the ligation product from step cc) with the fourth type IIS restriction enzyme which cuts outside of its recognition site, whereby the cleavage occurs in the fourth oligonucleotide in step cb), creating a second elongated product, wherein the second elongated product comprises the third oligonucleotide from step ca) which has been elongated,

cf) separating the second elongated product from the reaction mixture,

d) ligating the first and second elongated products from steps b) and c) in the orientation defined by the blocking of the ends not to be ligated,

e) removing unconsumed reactants as well as enzymes,

f) cleavage of the ligation product from step d) with a type IIS restriction enzyme, which cuts outside of its recognition site, whereby the cleavage occurs in the first or second elongated product from steps b) or c), creating a third elongation product,

g) separating the third elongation product from the reaction mixture, wherein the last repetition of steps bb) to bf) the first oligonucleotide added in step bb) carries a modification, which allows coupling to a solid matrix, and

h) isolating the nucleic acid molecule or part thereof having the sequence provided in step a).

8. The method according to claim 7, wherein after the last repetition of steps bb) to bf), as step bh), the ligation product from step be) is cut with a type IIS restriction enzyme which cuts outside of its recognition site, whereby the cleavage occurs in the nucleic acid sequence of the first oligonucleotide from step ba) and the cleavage product is released from the oligonucleotide coupled to the solid matrix, and the released cleavage product is divided into at least two reactions.

9. The method according to claim 7, characterized in that, following step bf), steps bb) to bf) are repeated at least once and/or, following step cf), steps cb) to cf) are repeated at least once, whereby, following the final ligation in step cc) and the removing of unconsumed reactants as well as enzymes, the ligation product is cut with a type IIS restriction enzyme, whereby the cleavage occurs in the third oligonucleotide from step ca).

10. The method according to claim 7, characterized in that the cleavage product released in step bh) is coupled to a solid matrix via the modification, and that the cleavage products that do not contain the modification are removed from the reaction.

11. The method according to claim 10, characterized in that, as step bi), in each of the reactions an oligonucleotide is added to the cleavage product coupled to the solid matrix from step bh), whereby the oligonucleotide contains a recognition site for a type IIS restriction enzyme which is different from the recognition site of a type IIS restriction enzyme of the cleavage product from step bh), with the oligonucleotide carrying a modification which allows coupling to a solid matrix, and, as step bk), the cleavage product from step bh) is ligated with the oligonucleotide.

12. The method according to claim 11, characterized in that the ligation product from step bk) is cut with a type IIS restriction enzyme which cuts outside of its recognition site, whereby the cleavage occurs in the nucleic acid sequence of the cleavage product from step bh).

13. The method according to claim 11, characterized in that the oligonucleotide added in step bi) has a different sequence in each reaction.

14. The method according to claim 7, characterized in that the oligonucleotides added to the reactions have identical single-stranded overhangs.

15. The method according to claim 7, characterized in that the oligonucleotides differ in a region that is different from the single-stranded region, preferably in a region comprising a sequence of nucleotides following the single-stranded region of the oligonucleotide.

16. The method according to claim 15, characterized in that the sequence of nucleotides has a length of 1 to 10 nucleotides, preferably 3 to 6 nucleotides.

17. The method according claim 7, characterized in that, in a step al), the oligonucleotide added in step bi) is cleaved.

18. The method according to claim 17, characterized in that the steps bb) to bk) and/or bl) are repeated at least once.

19. The method according to claim 18, characterized in that, after the last repetition, the oligonucleotides coupled to the solid phases are ligated, as step bm), with a further oligonucleotide according to bb), whereby these oligonucleotides in the different reactions differ from each other in the sequence of the single-stranded overhang and optionally in the sequence of the directly abutting double-stranded region.

20. The method according to claim 7, characterized in that, to the cleavage product coupled to the solid matrix from step bh), an oligonucleotide is added which contains a recognition site for a type IIS restriction enzyme that is different from the recognition site for a type IIS restriction enzyme of the cleavage product from step bh), the oligonucleotide carrying a modification which allows coupling to a solid matrix, and that, as step bi), the cleavage product from step bh) is ligated with the oligonucleotide.

21. The method according to claim 20, characterized in that the ligation product from step bi) is cut with a type IIS restriction enzyme which cuts outside of its recognition site, whereby the cleavage occurs in the nucleic acid sequence of the cleavage product from step bh).